4.7 Article

Whole Blood Transfusion for Severe Malarial Anemia in a High Plasmodium falciparum Transmission Setting

Journal

CLINICAL INFECTIOUS DISEASES
Volume 75, Issue 11, Pages 1893-1902

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac304

Keywords

severe malaria; severe malarial anemia; Plasmodium falciparum; blood transfusion; Zambia

Funding

  1. Johns Hopkins Malaria Research Institute
  2. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases as part of the Southern and Central Africa International Centers of Excellence for Malaria Research [U19AI089680]
  3. European and Developing Countries Clinical Trials Partnership
  4. National Institutes of Health [K23AI139343]
  5. Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases at Johns Hopkins University
  6. Burroughs Wellcome Fund-American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases
  7. Bloomberg Philanthropies

Ask authors/readers for more resources

A retrospective observational study in northern Zambia examined the impact of whole blood transfusion on survival of pediatric patients with severe malarial anemia. The results showed that transfusion was associated with greater survival, and thrombocytopenia was significantly associated with mortality and transfusion response. These findings highlight the importance of maintaining reliable blood donation networks in areas with high malaria transmission.
A retrospective observational study in northern Zambia of pediatric patients with severe malarial anemia examined the impact of whole blood transfusion on survival. Transfusion was associated with greater survival, and thrombocytopenia was significantly associated with mortality and transfusion response. Background Severe malaria resulting from Plasmodium falciparum infection is the leading parasitic cause of death in children worldwide, and severe malarial anemia (SMA) is the most common clinical presentation. The evidence in support of current blood transfusion guidelines for patients with SMA is limited. Methods We conducted a retrospective cohort study of 911 hospitalized children with SMA in a holoendemic region of Zambia to examine the association of whole blood transfusion with in-hospital survival. Data were analyzed in adjusted logistic regression models using multiple imputation for missing data. Results The median age of patients was 24 months (interquartile range, 16-30) and overall case fatality was 16%. Blood transfusion was associated with 35% reduced odds of death in children with SMA (odds ratio, 0.65; 95% confidence interval, .52-.81; P = .0002) corresponding to a number-needed-to-treat (NNT) of 14 patients. Children with SMA complicated by thrombocytopenia were more likely to benefit from transfusion than those without thrombocytopenia (NNT = 5). Longer storage time of whole blood was negatively associated with survival and with the posttransfusion rise in the platelet count but was not associated with the posttransfusion change in hemoglobin concentration. Conclusions Whole blood given to pediatric patients with SMA was associated with improved survival, mainly among those with thrombocytopenia who received whole blood stored for <4 weeks. These findings point to a potential use for incorporating thrombocytopenia into clinical decision making and management of severe malaria, which can be further assessed in prospective studies, and underline the importance of maintaining reliable blood donation networks in areas of high malaria transmission.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available